Last kr11.50 SEK
Change Today +0.05 / 0.44%
Volume 48.3K
BIOT On Other Exchanges
Symbol
Exchange
BIOT is not on other exchanges.
As of 6:59 AM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

biotage ab (BIOT) Snapshot

Open
kr11.50
Previous Close
kr11.45
Day High
kr11.75
Day Low
kr11.45
52 Week High
04/17/14 - kr11.75
52 Week Low
05/23/13 - kr8.00
Market Cap
803.4M
Average Volume 10 Days
476.1K
EPS TTM
kr0.62
Shares Outstanding
69.9M
EX-Date
04/29/14
P/E TM
18.6x
Dividend
kr0.60
Dividend Yield
4.35%
Current Stock Chart for BIOTAGE AB (BIOT)

Related News

No related news articles were found.

biotage ab (BIOT) Related Businessweek News

No Related Businessweek News Found

biotage ab (BIOT) Details

Biotage AB offers solutions, knowledge, and experience within analytical chemistry and medicinal chemistry, as well as separation and purification primarily in the United States, Europe, and Japan. The company provides instruments and related consumables for sample preparation, peptide synthesis and purification, evaporation, microwave synthesis, flash purification and work-up tools, and process tools in organic chemistry, analytical chemistry, and process chemistry areas. It also engages in contract-research services; and development and production of polymer based materials. The company sells its products to pharmaceutical companies, biotech- and biopharmaceutical companies, contract research organizations and contract manufacturing organizations, and academic institutions. Biotage AB is headquartered in Uppsala, Sweden.

289 Employees
Last Reported Date: 04/25/13

biotage ab (BIOT) Top Compensated Officers

Chief Executive Officer and President
Total Annual Compensation: kr3.3M
Compensation as of Fiscal Year 2012.

biotage ab (BIOT) Key Developments

Biotage AB Proposes Dividend, Payable on May 7, 2014

The board of directors of Biotage AB proposed a dividend of SEK 0.60 per share. Record date for dividend is proposed to be May 2, 2014. Payment of dividend is estimated to be effectuated by Euroclear Sweden AB on May 7, 2014.

Biotage AB Reports Unaudited Consolidated and Parent Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2013; Proposes Dividend for the Year Ended December 31, 2013

Biotage AB reported unaudited consolidated and parent earnings results for the fourth quarter and full year ended December 31, 2013. Group net sales in the quarter increased 7% and amounted to SEK 121.6 million, compared to SEK 113.9 million the corresponding period 2012. Operating profit amounted to SEK 13.4 million against SEK 13.5 million reported last year. Profit before income tax was SEK 16.5 million against SEK 10.4 million reported last year. Profit after tax for continuing operations was SEK 18.5 million or SEK 0.28 per share against SEK 13.6 million or SEK 0.19 per share reported last year. Net profit attributable to parent company's shareholders was SEK 18.5 million or SEK 0.28 per diluted share against SEK 13.6 million or SEK 0.19 per diluted share reported last year. Cash flow from operating activities amounted to SEK 21.1 million against SEK 29.9 million reported last year. Acquisition of property, plant and equipment was SEK 0.5 million against SEK 1.9 million reported last year. Group net sales decreased 4% in 2013 and amounted to SEK 444.6 million, compared to SEK 462.9 million reported in the same period last year. Operating profit amounted to SEK 39.2 million against SEK 43.8 million reported last year. Profit before income tax was SEK 40.4 million against SEK 38.3 million reported last year. Profit after tax for continuing operations was SEK 41.4 million or SEK 0.61 per share against SEK 38.6 million or SEK 0.52 per share reported last year. Net profit attributable to parent company's shareholders was SEK 41.4 million or SEK 0.61 per diluted share against SEK 38.3 million or SEK 0.52 per diluted share reported last year. Cash flow from operating activities amounted to SEK 56.8 million against SEK 67.5 million reported last year. Acquisition of property, plant and equipment was SEK 8.8 million against SEK 10.4 million reported last year. For the quarter, the parent company reported net sales of SEK 0.6 million against SEK 0.5 million reported in the same period last year. Operating loss amounted to SEK 3.2 million against SEK 6.5 million reported last year. Profit before income tax was SEK 145.0 million against SEK 21.2 million reported last year. Net profit was SEK 148.2 million against SEK 23.5 million reported last year. For the year, the parent company reported net sales of SEK 2.4 million against SEK 2.1 million reported in the same period last year. Operating loss amounted to SEK 3.2 million against SEK 6.5 million reported last year. Profit before income tax was SEK 178.6 million against SEK 12.8 million reported last year. Net profit was SEK 181.8 million against SEK 15.1 million reported last year. The group proposed a dividend of SEK 0.60 per share for the year ended December 31, 2013 as compared to SEK 0.50 per share paid a year ago.

Biotage AB Reports Consolidated and Parent Earnings Results for the Third Quarter and Nine Months Ended September 30, 2013

Biotage AB reported consolidated and parent earnings results for the third quarter and nine months ended September 30, 2013. For the quarter, on consolidated basis, the company reported net sales of SEK 103,418,000 against SEK 107,134,000 a year ago. Operating profit was SEK 7,610,000 against SEK 8,875,000 a year ago. Profit before income tax was SEK 7,179,000 against SEK 5,013,000 a year ago. Profit after tax for continuing operations was SEK 6,919,000 against SEK 3,669,000 a year ago. Total profit attributable to parent company’s shareholders was SEK 6,919,000 or SEK 0.10 per share after dilution against SEK 3,669,000 or SEK 0.05 per share after dilution a year ago. Cash flow from operating activities was SEK 14,164,000 against SEK 12,166,000 a year ago. Acquisition of intangible assets was SEK 6,743,000 against SEK 6,915,000 a year ago. Acquisition of property, plant and equipment was SEK 4,467,000 against SEK 1,290,000 a year ago. For the nine months, on consolidated basis, the company reported net sales of SEK 322,996,000 against SEK 349,000,000 a year ago. Operating profit was SEK 25,753,000 against SEK 30,329,000 a year ago. Profit before income tax was SEK 23,868,000 against SEK 27,905,000 a year ago. Profit after tax for continuing operations was SEK 22,906,000 against SEK 25,007,000 a year ago. Total profit attributable to parent company’s shareholders was SEK 22,906,000 or SEK 0.34 per share after dilution against SEK 24,719,000 or SEK 0.34 per share after dilution a year ago. Cash flow from operating activities was SEK 36,404,000 against SEK 44,539,000 a year ago. Acquisition of intangible assets was SEK 23,628,000 against SEK 21,067,000 a year ago. Acquisition of property, plant and equipment was SEK 8,362,000 against SEK 8,476,000 a year ago. For the quarter, on parent basis, the company reported net sales of SEK 601,000 against SEK 527,000 a year ago. Operating loss was SEK 4,435,000 against SEK 5,218,000 a year ago. Loss before income tax was SEK 2,701,000 against SEK 1,978,000 a year ago. Total loss was SEK 2,701,000 against SEK 1,977,000 a year ago. For the nine months, on parent basis, the company reported net sales of SEK 1,798,000 against SEK 1,593,000 a year ago. Operating loss was SEK 13,450,000 against SEK 16,907,000 a year ago. Profit before income tax was SEK 33,628,000 against loss of SEK 8,408,000 a year ago. Total profit was SEK 33,628,000 against loss of SEK 8,333,000 a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BIOT:SS kr11.50 SEK +0.05

BIOT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for BIOT.
View Industry Companies
 

Industry Analysis

BIOT

Industry Average

Valuation BIOT Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIOTAGE AB, please visit www.biotage.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.